US Tech 100

18,514.00

1.00%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
ETFs
USA
AMEX
iShares Robotics and Artificial Intelligence Multisector ETF (IRBO)
iShares Robotics and Artificial Intelligence Multisector ETF (IRBO) News

IRBO

iShares Robotics and Art... (IRBO)

iShares Robotics and Artificial Intelligence Multisector ETF

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:IRBO

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
08/27/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells	AMEX:IRBO
08/23/2007	6:00AM	PR Newswire (US)	ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information	AMEX:IRBO
08/16/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook	AMEX:IRBO
08/07/2007	7:00AM	PR Newswire (US)	ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.	AMEX:IRBO
07/23/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. to Present Homspera(TM) at 2007 BARDA Industry Day	AMEX:IRBO
07/19/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. and Virion Systems, Inc. Continue Testing Viprovex(R) and Tamiflu(R) as Possible Influenza Co-Trea	AMEX:IRBO
07/12/2007	8:16AM	PR Newswire (US)	ULURU Inc. Announces Co-Development Agreement for Potential Advanced Wound Care Therapeutic	AMEX:IRBO
07/12/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences Announces Development Partnership With Uluru Inc.	AMEX:IRBO
05/07/2007	7:00AM	PR Newswire (US)	IR BioSciences Announces Promising Data from Study of Its Compound Homspera	AMEX:IRBO
04/25/2007	9:07AM	PR Newswire (US)	IR BioSciences Appoints Celgene Executive Dr. Robert Hariri to Its Board of Directors	AMEX:IRBO
03/20/2007	8:08AM	PR Newswire (US)	ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent	AMEX:IRBO
03/14/2007	10:47AM	PR Newswire (US)	IR BioSciences, Inc. Responds to the Recently Cancelled Acute Radiation Syndrome (ARS) RFP by DHHS	AMEX:IRBO
03/08/2007	9:11AM	PR Newswire (US)	IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal	AMEX:IRBO
02/26/2007	6:00AM	PR Newswire (US)	IR BioSciences Holdings, Inc. to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiati	AMEX:IRBO
02/08/2007	5:32PM	PR Newswire (US)	/C O R R E C T I O N -- ImmuneRegen BioSciences, Inc./	AMEX:IRBO
02/08/2007	7:00AM	PR Newswire (US)	ImmuneRegen's Viprovex Demonstrates Immune Response Potential in Treatment of Avian Influenza and Spanish Flu	AMEX:IRBO
01/18/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Retains Battelle for Radiation and Infectious Disease Testing	AMEX:IRBO
01/16/2007	6:00AM	PR Newswire (US)	ImmuneRegen Achieves Key Milestone in Testing of Potential Infectious Disease Treatment	AMEX:IRBO
01/09/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Demonstrates That Viprovex(TM) Is a Potential Treatment for Avian and Other Influenzas	AMEX:IRBO
01/04/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Announces First Study of Viprovex(TM) to Explore Adjuvant Capabilities in the Area of Pandemic Inf	AMEX:IRBO
01/04/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences, Inc. Announces First Study of Viprovex(TM) to Explore Adjuvant Capabilities in the Area of Pandemic Inf	AMEX:IRBO
01/03/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences Appoints Hal Siegel, Ph.D. as Senior Director of Product Development & Regulatory Affairs	AMEX:IRBO
01/03/2007	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences Appoints Hal Siegel, Ph.D. as Senior Director of Product Development & Regulatory Affairs	AMEX:IRBO
12/11/2006	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences Responds to Department of Health and Human Services Request for Information for Medical Countermeasures	AMEX:IRBO
12/07/2006	6:00AM	PR Newswire (US)	ImmuneRegen BioSciences Closes Round of Funding	AMEX:IRBO
08/30/2006	7:30AM	PR Newswire (US)	ImmuneRegen Begins Next Study With Oak Ridge National Laboratory (ORNL)	AMEX:IRBO
08/17/2006	7:00AM	PR Newswire (US)	ImmuneRegen Announces Further Results From Anthrax Treatment Study	AMEX:IRBO
08/02/2006	7:00AM	PR Newswire (US)	ImmuneRegen Product to be Tested as Defense to Potential Biological Weapon	AMEX:IRBO
07/31/2006	7:00AM	PR Newswire (US)	Singapore's DSO National Laboratories to Study ImmuneRegen's Viprovex(TM)	AMEX:IRBO
07/24/2006	7:00AM	PR Newswire (US)	NIH to Conduct Preclinical Evaluation of ImmuneRegen's Radilex(TM)	AMEX:IRBO